69 related articles for article (PubMed ID: 432599)
21. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
Fodor J; Polgár C; Major T; Németh G
Strahlenther Onkol; 2003 Mar; 179(3):197-202. PubMed ID: 12627264
[TBL] [Abstract][Full Text] [Related]
22. Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.
Reddy SG; Kiel KD
Breast J; 2007; 13(1):12-8. PubMed ID: 17214788
[TBL] [Abstract][Full Text] [Related]
23. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
Yu J; Li G; Li J; Wang Y
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
25. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.
Kuerer HM; Newman LA; Buzdar AU; Dhingra K; Hunt KK; Buchholz TA; Binkley SM; Strom EA; Ames FC; Ross MI; Feig BW; McNeese MD; Hortobagyi GN; Singletary SE
Cancer J Sci Am; 1998; 4(4):230-6. PubMed ID: 9689981
[TBL] [Abstract][Full Text] [Related]
26. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
28. Identifying good prognosis group of breast cancer patients with 1-3 positive axillary nodes for adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF) chemotherapy.
Lin YC; Chen SC; Chang HK; Hsueh S; Tsai CS; Lo YF; Hwang TL; Chen MF
Jpn J Clin Oncol; 2005 Sep; 35(9):514-9. PubMed ID: 16199422
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
30. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
Fisher B; Slack N; Katrych D; Wolmark N
Surg Gynecol Obstet; 1975 Apr; 140(4):528-34. PubMed ID: 805475
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
[TBL] [Abstract][Full Text] [Related]
32. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.
Hwang RF; Gonzalez-Angulo AM; Yi M; Buchholz TA; Meric-Bernstam F; Kuerer HM; Babiera GV; Tereffe W; Liu DD; Hunt KK
Cancer; 2007 Aug; 110(4):723-30. PubMed ID: 17587208
[TBL] [Abstract][Full Text] [Related]
33. [A multivariate analysis of en bloc extended radical mastectomy versus conventional radical mastectomy in operable breast cancer].
Noguchi M; Taniya T; Koyasaki N; Miyazaki I
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):883-8. PubMed ID: 2398881
[TBL] [Abstract][Full Text] [Related]
34. The primary surgical treatment of carcinoma of the breast: a changing trend toward modified radical mastectomy.
Robinson GN; van Heerden JA; Payne WS; Taylor WF; Gaffey TA
Mayo Clin Proc; 1976 Jul; 51(7):433-42. PubMed ID: 933559
[TBL] [Abstract][Full Text] [Related]
35. [Preoperative radiotherapy and curative radiotherapy without mastectomy in carcinoma of the breast (author's transl)].
Sauer R
Rontgenblatter; 1978 Jul; 31(7):417-22. PubMed ID: 99799
[TBL] [Abstract][Full Text] [Related]
36. Does radical surgery to the axilla give a survival advantage in more severe breast cancer?
Sinha PS; Thrush S; Bendall S; Bates T
Eur J Cancer; 2002 Jul; 38(11):1474-7. PubMed ID: 12110493
[TBL] [Abstract][Full Text] [Related]
37. Management and survival of female patients with "minimal" breast cancer: as observed in the long-term and short-term surveys of the American College of Surgeons.
Bedwani R; Vana J; Rosner D; Schmitz RL; Murphy GP
Cancer; 1981 Jun; 47(12):2769-78. PubMed ID: 7260868
[TBL] [Abstract][Full Text] [Related]
38. Comparison of adjuvant postoperative radiotherapy and multiple-drug chemotherapy (CMF-VP) in operable breast cancer patients with more than four positive axillary lymph nodes.
Chu AM; Kiel K
Cancer; 1982 Jul; 50(2):212-8. PubMed ID: 7083128
[TBL] [Abstract][Full Text] [Related]
39. Management of operable breast cancer: the surgeon's view.
Urban JA
Cancer; 1978 Oct; 42(4):2066-77. PubMed ID: 101302
[TBL] [Abstract][Full Text] [Related]
40. Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes.
Arriagada R; Lê MG; Mouriesse H; Fontaine F; Dewar J; Rochard F; Spielmann M; Lacour J; Tubiana M; Sarrazin D
Radiother Oncol; 1988 Mar; 11(3):213-22. PubMed ID: 3363169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]